GABELLI UTILITY TRUST 8-K

What Happened

• The Fund filed an 8-K (filed May 7, 2026) reporting that Trustee, Chairman and Chief Investment Officer Mario J. Gabelli was hospitalized for observation after a medical incident on March 19, 2026. His condition is improving but no timeline for return is known.
• On March 22, 2026 GAMCO (parent of the Fund’s adviser, Gabelli Funds, LLC) implemented a pre-existing succession plan. Christopher J. Marangi was named President of GAMCO and will share day-to-day leadership with co-CEO Douglas R. Jamieson.

Key Details

• Medical incident date: March 19, 2026; GAMCO succession implemented: March 22, 2026; GAMCO statement issued March 23, 2026.
• Roles affected: Mario J. Gabelli serves as Trustee, Chairman and CIO of the Fund and holds senior investment roles at GAMCO; Christopher J. Marangi is named President of GAMCO.
• Portfolio management during Mr. Gabelli’s absence: Gabelli Value team Co-Chief Investment Officers Kevin V. Dreyer and Christopher J. Marangi are leading the Fund’s portfolio management.
• Filing date of the 8-K: May 7, 2026.

Why It Matters

• Operational continuity: The adviser activated an established succession plan, naming experienced leaders to run day-to-day operations and lead portfolio management, which helps maintain investment oversight and strategy continuity.
• No immediate change to Fund strategy disclosed: The filing does not announce changes to the Fund’s investment approach or other material financial items, but notes the timeline for Mr. Gabelli’s return is unknown—investors should monitor updates for any further developments.